A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in Blood ...

Intravenous (IV) iron use overall is associated with a “very low” risk for anaphylaxis, but iron dextran and ferumoxytol carry an increased risk relative to iron sucrose, according to new research.

IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.

Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a ...

Intravenous (IV) iron therapy is more effective than oral drugs for women with anemia and heavy periods, providing better ...

Please provide your email address to receive an email when new articles are posted on . The risk for anaphylaxis from IV iron formulations appeared low, although it varied depending on the type of ...

The comparative study aimed to analyze AEs as well as estimate the associated medical costs for 4 IV iron preparations. Hypersensitivity and anaphylactic reaction rates reported to the US Food and ...

During a period of rapid fluctuation in the intravenous iron market, there was increased use of a more expensive drug that afforded providers additional revenue. Objectives: Medicare Part B payment ...

The chances of a severe allergic reaction being triggered by intravenous (IV) iron formulations for anemia are higher with some than others, but all pose a low risk, a new study says. Researchers ...

IntravenoIron Drugs Market, By Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, and Others), By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, and Others), and By ...